Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07816341 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase 1 Study of F182112 in Relapsed/Refractory Autoimmune Hemolytic Anemia

StatusNot Yet Recruiting
PhasePhase 1
Started2026-10-10
View on ClinicalTrials.gov ↗
This is an open-label, phase I clinical study of F182112 in patients with relapsed or refractory autoimmune hemolytic anemia (AIHA). Participants will receive F182112 at different dose levels. The main purpose of the study is to evaluate the safety and tolerability of F182112 and to identify an appropriate dose for further clinical development.
Trial Details
NCT Number NCT07816341
Lead Sponsor Institute of Hematology & Blood Diseases Hospital, China
Conditions Autoimmune Hemolytic Anemia
Enrollment 12 participants
Start Date 2026-10-10
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-11